Bone mass measurements in men and women with chronic kidney disease

Current Opinion in Nephrology and Hypertension

Volumn 19, Issue 4, 2010, Pages 343-348

  Jamal, Sophie A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

bone mineral density testing; fracture; metabolic bone disease; osteoporosis

Indexed keywords

BONE DENSITOMETRY; BONE DENSITY; BONE MASS; BONE STRENGTH; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; GLOMERULUS FILTRATION RATE; HIGH RESOLUTION PERIPHERAL QUANTITATIVE COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MALE; NEUROMUSCULAR FUNCTION; OSTEOPOROSIS; PERIPHERAL QUANTITATIVE COMPUTER ASSISTED TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; ANATOMY AND HISTOLOGY; ANIMAL; BONE; CHRONIC KIDNEY FAILURE; COMPLICATION; FRACTURES, BONE; METABOLISM; PATHOLOGY; PHOTON ABSORPTIOMETRY; RISK FACTOR;

ABSORPTIOMETRY, PHOTON; ANIMALS; BONE AND BONES; BONE DENSITY; FRACTURES, BONE; HUMANS; KIDNEY FAILURE, CHRONIC; RISK FACTORS;

EID: 77954086137     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328338f520     Document Type: Review

References (57)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
2. Jamal SA. Fractures in men and women with dialysis-dependent renal failure. St. Michael's Hosp Endocrinol Rounds 2003; 3:1-6.
3. Jamal SA, Gilbert J, Gordon C, Bauer DC. Cortical PQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 2006; 21:543-548.
4. Jamal SA, Leiter RE, Jassal V, et al. Impaired muscle strength is associated with fractures in hemodialysis patients. Osteoporosis Int 2006; 17:1390-1397.
5. Malluche HH, Faugere MC. Renal osteodystrophy. N Engl J Med 1989; 321:317-318.
6. Lindberg JS, Moe SM. Osteoporosis in end-state renal disease. Semin Nephrol 1999; 19:115-122.
7. Atsumi K, Kushida K, Yamazaki K, et al. Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 1999; 33:287-293.
8. Chan YL, Furlong TJ, Cornish CJ, Posen S. Dialysis osteodystrophy. A study involving 94 patients. Medicine (Baltimore) 1985; 64:296-309.
9. Schaab PC, Murphy G, Tzamaloukas AH, et al. Femoral neck fractures in patients receiving long-term dialysis. Clin Orthop1990; 260:224-231.
10. Vonesh EF, Moran J. Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999; 10:354-365.
11. Eknoyan G. Cardiovascular mortality and morbidity in dialysis patients. Miner Electrolyte Metab 1999; 25:100-104.
12. Ensrud KE, Lui LY, Taylor BC, et al. Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 2007; 167:133-139.
13. Nickolas TL, McMahon DJ, Shane E. Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 2006; 17:3223-3232.
14. Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 2000; 36:1115-1121.
15. MoeS, DruekeT, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease Improving Global Outcomes (KDIGO). Kidney Int 2006; 69:1945-1953.
16. National Institutes of Health. Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Statement 2000; 17:1-45.
17. Miller PD. Diagnosis and treatment of osteoporosis in chronic renal disease. Semin Nephrol 2009; 29:144-155.
18. Miller PD. Fragility fractures in chronic kidney disease: an opinion-based approach. Cleveland Clin J Med 2009; 76:715-723.
19. Sakhaee K, Gonzalez GB. Update on renal osteodystrophy: pathogenesis and clinical management. Am J Med Sci 1999; 317:251-260.
20. Heaney RP. Is the paradigm shifting? Bone 2003; 33:457-465.
21. Jee WS. The past, present, and future of bone morphometry: its contribution to an improved understanding of bone biology. J Bone Miner Metab 2005; 23 (Suppl):1-10.
22. Parfitt AM. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry. Curr Opin Nephrol Hypertens 2003; 12:387-403.
23. Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ 1995; 311:485.
24. Miller PD, Zapalowski C, Kulak CA, Bilezikian JP. Bone densitometry: the best way to detect osteoporosis and to monitor therapy. J Clin Endocrinol Metab 1999; 84:1867-1871.
25. RixM, Andreassen H, Eskildsen P, et al. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 1999; 56:1084-1093.
26. HsuCY, CummingsSR, McCulloch CE, ChertowGM. Bone mineral density is not diminished by mild to moderate chronic renal insufficiency. Kidney Int 2002; 61:1814-1820.
27. Ishani A, Paudel M, Taylor BC, et al. Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Osteoporos Int 2008; 19:1549-1556.
28. Jassal SK, von Muhlen D, Barrett-Connor E. Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res 2007; 22:203-210.
29. Jamal SA, Swan VJ, Brown JP, et al. Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study. Am J Kidney Dis 2009; 55:291-299.
30. Miller PD, Roux C, Boonen S, et al. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cock-croft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res 2005; 20:2105-2115.
31. Jamal SA, Bauer DC, Ensrud KE, et al. Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res 2007; 22:503-508.
32. Ishani A, Blackwell T, Jamal SA, et al. The effect of raloxifene treatment in postmenopausal women with kidney disease. J Am Soc Nephrol 2008; 19: 1430-1438.
33. Miller PD, Schwartz EN, Chen P, et al. Teriparatide inpostmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int 2007; 18:59-68.
34. Yamaguchi T, Kanno E, Tsubota J, et al. Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. Bone 1996; 19:549-555.
35. Fontaine MA, Albert A, Dubois B, et al. Fracture and bone mineral density in hemodialysis patients. Clin Nephrol 2000; 54:218-226.
36. Jamal SA, Chase C, Goh Y, et al. Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. Am J Kidney Dis 2002; 39:843-849.
37. Kaji H, Suzuki M, Yano S, et al. Risk factors for hip fracture in hemodialysis patients. Am J Nephrol 2002; 22:325-331.
38. Urena P, Bernard-Poenaru O, Ostertag A, et al. Bone mineral density, biochemical markers and skelet al fractures in haemodialysis patients. Nephrol Dial Transplant 2003; 18:2325-2331.
39. Inaba M, Okuno S, Kumeda Y, et al. Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus. Calc Tissue Int 2005; 76:256-260.
40. Gerakis A, Hadjidakis D, Kokkinakis E, et al. Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol 2000; 13:437-443.
41. Negri AL, Barone R, Quiroga MA, et al. Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis. Perit Dial Int 2004; 24:163-168.
42. Dolgos S, Hartmann A, Bonsnes S, et al. Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation. Clin Transplant 2008; 22:462-468.
43. Elder GJ, Mackun K. 25-hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease. J Bone Miner Res 2006; 21:1778-1784.
44. Ersoy FF, Passadakis SP, Tam P, et al. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J Bone Miner Metab 2006; 24:79-86.
45. Jamal SA, Hayden JA, Beyene J. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis 2007; 49:674-681.
46. Duan Y, De Luca V, Seeman E. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J Clin Endocrinol Metab 1999; 84:718-722.
47. Christiansen P, Steiniche T, Brockstedt H, et al. Primary hyperparathyroidism: iliac crest cortical thickness, structure, and remodeling evaluated by histo-morphometric methods. Bone 1993; 14:755-762. (Pubitemid 23294029)
48. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 2009; 76:S1-S130.
49. Ashe MC, Khan KM, Kontulainen SA, et al. Accuracy of pQCT for evaluating the aged human radius: an ashing, histomorphometry and failure load investigation. Osteoporos Int 2006; 17:1241-1251.
50. Kontulainen S, Liu D, Manske S, et al. Analyzing cortical bone cross-sectional geometry by peripheral QCT: comparison with bone histomorphometry. J Clin Densitom 2007; 10:86-92.
51. Parfitt AM. A structural approach to renal bone disease. J Bone Miner Res 1998; 13:1213-1220.
52. Russo CR, Taccetti G, Caneva P, et al. Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis. Osteoporos Int 1998; 8:443-448.
53. Hasegawa K, Hasegawa Y, Nagano A. Estimation of bone mineraldensity and architectural parameters of the distal radius in hemodialysis patients using peripheral quantitative computed tomography. J Biomech 2004; 37:751-756.
54. Negri AL, Barone R, Lombas C, et al. Evaluation of cortical bone by peripheral quantitative computed tomography in continuous ambulatory peritoneal dialysis patients. Hemodial Int 2006; 10:351-355.
55. Obatake N, Ishimura E, Tsuchida T, et al. Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D. J Bone Miner Metab 2007; 25:74-79.
56. Bouxsein ML. Noninvasive measurements of bone strength: promise and peril. J Musculoskelet Neuron Interact 2004; 4:404-405.
57. Wehrli FW, Leonard MB, Saha PK, Gomberg BR. Quantitative high-resolution magnetic resonance imaging reveals structural implications of renal osteo dystrophy on trabecular and cortical bone. J Magn Reson Imaging 2004; 20:83-89.